InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Tuesday, 04/04/2023 10:02:59 AM

Tuesday, April 04, 2023 10:02:59 AM

Post# of 6093
ABUS/Genevant* sue PFE/BNTX re LNP technology_in_COVID_vaccine:

https://finance.yahoo.com/news/arbutus-biopharma-genevant-sciences-file-115200610.html

Arbutus Biopharma Corporation..and Genevant Sciences (Genevant) today filed a lawsuit in the U.S. District Court for the District of New Jersey against Pfizer Inc. and BioNTech SE seeking damages for infringement of U.S. Patent Nos. 9,504,651; 8,492,359; 11,141,378; 11,298,320; and 11,318,098 in the manufacture and sale of any COVID-19 mRNA-LNP vaccines. The patents relate to nucleic acid-lipid particles and their composition, manufacture, delivery and methods of use.

William Collier, President and CEO of Arbutus, stated, “…We believe that Pfizer and BioNTech could not have created and manufactured effective vaccines at such an unprecedented speed without the existing, proven and patented LNP technologies owned by Arbutus and licensed to Genevant

Seems like a rather weak rationale for alleging infringement. Also, why was there a 13-month delay between the filing of this lawsuit against PFE/BNTX and the similar suit by against MRNA?

*Genevant Sciences is a JV of ABUS and ROIV.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News